Skip to main content
Tech.euFundingExplorerBeta

Miracor Medical Systems

Develops a PREssure-controlled intermittent coronary sinus occlusion technology for heart patients

Miracor Medical Systems has raised €15M across 3 funding rounds from 3 investors, most recently a Series B round in Jan 2015. Based in Vienna, Austria; founded 2008; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€15M
€14,562,107
Funding rounds
3
Investors
3
distinct backers
Active since
2011-10
latest 2015-01

Funding by year

EUR raised per year
Miracor Medical Systems — funding by year — interactive chart.
Data table
Miracor Medical Systems — funding by year
2011€7.4M
2012€2.7M
2014€4.5M

Signals

High confidence
Raise-next likelihood11
base rate 48% for Series B
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
Exit likelihood7
base rate 11% (2+ rounds)
  • ▼ Old (18y) — past typical exit age
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2015-01-01Series B€4.5MBioMedPartners,Earlybird Venture CapitalView deal →
2012-02-01Grant€2.7M—View deal →
2011-10-01Series B€7.4MAustria Wirtschaftsservice,Earlybird Venture CapitalView deal →

Similar companies

same sector or country

Global coverage: FundingData